Sign up to save your podcasts
Or
Share HealthTech 101: Strategic VC Insights to Approach the Healthcare Industry. A chat with Andrew Rubenstein, Founding Partner @ Shorewind Capital
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HealthTech 101: Strategic VC Insights to Approach the Healthcare Industry. A chat with Andrew Rubenstein, Founding Partner @ Shorewind Capital
Host: Nicola Marchese
Guest: Andrew Rubenstein, Founding Partner at Shorewind Capital
#DeepTechCatalyst
Watch the full video on our platform!
KEY TAKEAWAYS:
1. HealthTech companies can often bypass traditional healthcare systems and regulations, allowing them to reach consumers more quickly, whereas MedTech typically requires regulatory approval and deeper integration with healthcare providers and insurers.
2. The industry is shifting from a reactive “sick care” model to a proactive, prevention-focused approach, supported by at-home testing and AI-driven data analysis to identify and address health issues before symptoms appear.
3. Current insurance models don’t incentivize long-term preventive care because patients frequently change plans. Until value-based payment models become standard, achieving widespread adoption of preventive solutions will remain challenging.
4. Companies should commit to either a consumer health or a traditional healthcare model from the start. Attempting to switch midstream is often costly, time-consuming, and culturally difficult.
5. Consumer health branding focuses on wellness, performance, and lifestyle, appealing directly to users. In contrast, traditional healthcare branding emphasizes reliability, scientific rigor, and trust, aiming at doctors, insurers, and regulatory bodies.
6. HealthTech products can often launch earlier and gather customer data quickly. Traditional healthcare devices typically face longer timelines due to regulatory requirements, demanding specialized investors comfortable with scientific validation over immediate revenue.
MORE ABOUT THE SCENARIONIST:
- Discover all the episodes, trends analysis, and more.
- Stay in the loop with our latest news.
- Let’s connect.
#Fundraising #Startups #DeepTech #VentureCapital #Healthcare #HealthTech #AI #D2C #VCs #HardTech #industry #tech #strategy #founders #technology #entrepreneurship
Disclaimer: This content is provided solely for educational and informational purposes and should not be interpreted as financial or legal advice. Given the complexity and potential impact of these terms, it is crucial to consult with an attorney. Legal expertise is invaluable in navigating these technical aspects and ensuring that the terms are in your best interests before finalizing any agreements.
View all episodes
By The ScenarionistHost: Nicola Marchese
Guest: Andrew Rubenstein, Founding Partner at Shorewind Capital
#DeepTechCatalyst
Watch the full video on our platform!
KEY TAKEAWAYS:
1. HealthTech companies can often bypass traditional healthcare systems and regulations, allowing them to reach consumers more quickly, whereas MedTech typically requires regulatory approval and deeper integration with healthcare providers and insurers.
2. The industry is shifting from a reactive “sick care” model to a proactive, prevention-focused approach, supported by at-home testing and AI-driven data analysis to identify and address health issues before symptoms appear.
3. Current insurance models don’t incentivize long-term preventive care because patients frequently change plans. Until value-based payment models become standard, achieving widespread adoption of preventive solutions will remain challenging.
4. Companies should commit to either a consumer health or a traditional healthcare model from the start. Attempting to switch midstream is often costly, time-consuming, and culturally difficult.
5. Consumer health branding focuses on wellness, performance, and lifestyle, appealing directly to users. In contrast, traditional healthcare branding emphasizes reliability, scientific rigor, and trust, aiming at doctors, insurers, and regulatory bodies.
6. HealthTech products can often launch earlier and gather customer data quickly. Traditional healthcare devices typically face longer timelines due to regulatory requirements, demanding specialized investors comfortable with scientific validation over immediate revenue.
MORE ABOUT THE SCENARIONIST:
- Discover all the episodes, trends analysis, and more.
- Stay in the loop with our latest news.
- Let’s connect.
#Fundraising #Startups #DeepTech #VentureCapital #Healthcare #HealthTech #AI #D2C #VCs #HardTech #industry #tech #strategy #founders #technology #entrepreneurship
Disclaimer: This content is provided solely for educational and informational purposes and should not be interpreted as financial or legal advice. Given the complexity and potential impact of these terms, it is crucial to consult with an attorney. Legal expertise is invaluable in navigating these technical aspects and ensuring that the terms are in your best interests before finalizing any agreements.